DK3301115T3 - Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer - Google Patents

Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer Download PDF

Info

Publication number
DK3301115T3
DK3301115T3 DK17200909.4T DK17200909T DK3301115T3 DK 3301115 T3 DK3301115 T3 DK 3301115T3 DK 17200909 T DK17200909 T DK 17200909T DK 3301115 T3 DK3301115 T3 DK 3301115T3
Authority
DK
Denmark
Prior art keywords
antibodies
purification
step procedure
continuous multi
continuous
Prior art date
Application number
DK17200909.4T
Other languages
Danish (da)
English (en)
Inventor
Didier Duthe
Céline Hemet
Laure Landric-Burtin
Benoît Mothes
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK3301115T3 publication Critical patent/DK3301115T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Water Supply & Treatment (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK17200909.4T 2013-05-06 2014-05-06 Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer DK3301115T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
EP14722194.9A EP2994485B1 (en) 2013-05-06 2014-05-06 Continuous multistep process for purifying antibodies

Publications (1)

Publication Number Publication Date
DK3301115T3 true DK3301115T3 (da) 2022-01-31

Family

ID=48430636

Family Applications (2)

Application Number Title Priority Date Filing Date
DK17200909.4T DK3301115T3 (da) 2013-05-06 2014-05-06 Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer
DK14722194.9T DK2994485T3 (en) 2013-05-06 2014-05-06 CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14722194.9T DK2994485T3 (en) 2013-05-06 2014-05-06 CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES

Country Status (19)

Country Link
US (1) US10793622B2 (cg-RX-API-DMAC7.html)
EP (2) EP3301115B1 (cg-RX-API-DMAC7.html)
JP (2) JP6463734B2 (cg-RX-API-DMAC7.html)
KR (1) KR102272851B1 (cg-RX-API-DMAC7.html)
CN (2) CN105358572A (cg-RX-API-DMAC7.html)
AU (1) AU2014264697B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015027812B1 (cg-RX-API-DMAC7.html)
CA (1) CA2911462C (cg-RX-API-DMAC7.html)
CY (1) CY1125281T1 (cg-RX-API-DMAC7.html)
DK (2) DK3301115T3 (cg-RX-API-DMAC7.html)
ES (2) ES2905675T3 (cg-RX-API-DMAC7.html)
HU (2) HUE038741T2 (cg-RX-API-DMAC7.html)
IL (1) IL242408B (cg-RX-API-DMAC7.html)
MX (1) MX368177B (cg-RX-API-DMAC7.html)
NO (1) NO2994485T3 (cg-RX-API-DMAC7.html)
RU (1) RU2662668C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201508968XA (cg-RX-API-DMAC7.html)
TW (2) TWI675041B (cg-RX-API-DMAC7.html)
WO (1) WO2014180852A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
MX379269B (es) * 2012-10-24 2025-03-11 Genzyme Corp Elucion de biomoleculas de resinas multimodales utilizando mes y mops como modificadores de fase movil.
US10519195B2 (en) * 2013-09-17 2019-12-31 Kaneka Corporation Antibody purification method, antibody obtained therefrom, novel antibody purification method using cation exchanger, and antibody obtained therefrom
EP3092049A1 (en) 2014-01-08 2016-11-16 Flodesign Sonics Inc. Acoustophoresis device with dual acoustophoretic chamber
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (de) 2015-05-07 2016-05-04 Bayer Technology Services GmbH Modulare anlage und verfahren zur kontinuierlichen, keimreduzierten produktion und/oder aufbereitung eines produktes
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
WO2018051348A1 (en) * 2016-09-14 2018-03-22 Insight Biopharmaceutical Ltd. Methods of purifying and qualifying antibodies
KR20190127655A (ko) 2016-10-19 2019-11-13 프로디자인 소닉스, 인크. 음향학에 의한 친화성 세포 추출
EP3601332A1 (en) * 2017-03-24 2020-02-05 Council of Scientific and Industrial Research A process for the purification of recombinant antibody fragments
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
KR102286260B1 (ko) * 2017-08-31 2021-08-05 주식회사 녹십자 설파타아제 단백질을 정제하는 방법
JP2021507561A (ja) 2017-12-14 2021-02-22 フロデザイン ソニックス, インク.Flodesign Sonics, Inc. 音響トランスデューサドライバ及びコントローラ
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (en) 2018-10-08 2020-04-15 Ablynx N.V. Chromatography-free antibody purification method
WO2020084503A1 (en) * 2018-10-26 2020-04-30 Cadila Healthcare Limited A composition comprising antibody with reduced level of basic variants thereof
WO2020183332A1 (en) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification of adalimumab using tandem chromatography
WO2020205928A1 (en) * 2019-04-03 2020-10-08 Genzyme Corporation Continuous production of recombinant proteins
CN114026108B (zh) * 2019-06-28 2024-09-10 夏尔巴生物技术(苏州)有限公司 无缝连续流层析方法
AU2020356303A1 (en) * 2019-09-23 2022-04-14 Merck Sharp & Dohme Llc Methods and compositions comprising an anti-CTLA4 monoclonal antibody with reduced host cell proteins and increased polysorbate-80 stability
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (en) 2021-05-03 2022-11-10 Lupin Limited A process for purification of fc-fusion proteins

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE121418T1 (de) 1987-10-23 1995-05-15 Schering Corp Verfahren zur proteinreinigung.
JP4057049B2 (ja) 1993-09-21 2008-03-05 ヘモソル インコーポレーテッド 置換クロマトグラフィー法および精製ヘモグロビン産物
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
PT1745075E (pt) 2004-04-21 2013-06-17 Brigham & Womens Hospital Péptidos de ligação a poli-n-acetilglucosamina (pnag/dpnag) e métodos da sua utilização
ES2612572T3 (es) * 2004-10-21 2017-05-17 Ge Healthcare Bioprocess R&D Ab Matriz de cromatografía
NZ586780A (en) 2005-03-23 2012-02-24 Genmab As Antibodies against CD38 for treatment of multiple myeloma
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (en) * 2006-10-19 2008-04-23 Sanofi-Aventis Novel anti-CD38 antibodies for the treatment of cancer
KR101293504B1 (ko) 2007-07-11 2013-08-07 노보 노르디스크 에이/에스 혼합형 또는 다중형 수지를 사용하는 인자 vⅰⅰⅰ의 정제
PT2207568T (pt) 2007-11-16 2017-09-01 Univ Rockefeller Anticorpos específicos para a forma de protofibrilha da proteína beta-amilóide
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至her2結構域ii之抗體及其酸性變異體的組合物
AU2009222115A1 (en) * 2008-02-29 2009-09-11 Biogen Idec Ma Inc. Purified immunoglobulin fusion proteins and methods of their purification
US20110105725A1 (en) * 2008-05-15 2011-05-05 Novo Nordisk A/S Antibody purification process
US20110237781A1 (en) * 2008-07-18 2011-09-29 Talecris Biotherapeutics, Inc. Method of preparing alpha-1 proteinase inhibitor
WO2010071208A1 (ja) 2008-12-19 2010-06-24 武田薬品工業株式会社 抗体の精製方法
WO2010082894A1 (en) 2009-01-13 2010-07-22 Ge Healthcare Bio-Sciences Ab Precipitation of biomolecules with negatively charged polymers
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
KR101415660B1 (ko) * 2009-08-07 2014-07-16 이엠디 밀리포어 코포레이션 샘플 중의 1 이상의 불순물로부터 표적 단백질을 정제하는 방법
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (en) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
US20130178608A1 (en) * 2009-12-29 2013-07-11 Samir Kulkarni Protein purification by ion exchange
EP2415779B1 (en) 2010-08-02 2015-01-21 ratiopharm GmbH Method of producing and purifying an active soluble sialyltransferase
WO2012125735A1 (en) * 2011-03-15 2012-09-20 Abott Laboratories An integrated approach to the isolation and purification of antibodies
KR102058254B1 (ko) * 2011-03-29 2019-12-20 글락소스미스클라인 엘엘씨 단백질 정제용 완충제 시스템
CA2839542A1 (en) 2011-06-17 2012-12-20 Constitution Medical, Inc. Fixative and staining solutions
US9096648B2 (en) 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
EP2578286A1 (en) * 2011-10-04 2013-04-10 Merck Patent GmbH Method and apparatus for chromatographic purification
US20140302021A1 (en) * 2011-10-25 2014-10-09 Onclave Therapeutics Limited Antibody formulations and methods
WO2013075740A1 (en) * 2011-11-23 2013-05-30 Sanofi Antibody purification method

Also Published As

Publication number Publication date
RU2015151869A (ru) 2017-06-13
CA2911462A1 (en) 2014-11-13
JP2019104735A (ja) 2019-06-27
TW201522363A (zh) 2015-06-16
KR102272851B1 (ko) 2021-07-02
HUE057119T2 (hu) 2022-04-28
EP2994485B1 (en) 2018-01-10
CN116003579A (zh) 2023-04-25
BR112015027812A2 (pt) 2017-07-25
US20160083454A1 (en) 2016-03-24
NO2994485T3 (cg-RX-API-DMAC7.html) 2018-06-09
BR112015027812B1 (pt) 2021-03-30
HUE038741T2 (hu) 2018-11-28
JP6463734B2 (ja) 2019-02-06
AU2014264697B2 (en) 2019-08-22
CA2911462C (en) 2021-04-06
SG11201508968XA (en) 2015-11-27
US10793622B2 (en) 2020-10-06
EP2994485A1 (en) 2016-03-16
AU2014264697A1 (en) 2015-11-26
WO2014180852A1 (en) 2014-11-13
DK2994485T3 (en) 2018-04-23
MX368177B (es) 2019-09-23
ES2905675T3 (es) 2022-04-11
CY1125281T1 (el) 2023-06-09
JP2016519137A (ja) 2016-06-30
EP3301115B1 (en) 2021-11-10
CN105358572A (zh) 2016-02-24
EP3301115A1 (en) 2018-04-04
RU2662668C2 (ru) 2018-07-26
ES2665645T3 (es) 2018-04-26
TW201908331A (zh) 2019-03-01
MX2015015482A (es) 2016-03-21
KR20160005047A (ko) 2016-01-13
IL242408B (en) 2020-04-30
TWI631132B (zh) 2018-08-01
TWI675041B (zh) 2019-10-21

Similar Documents

Publication Publication Date Title
DK3301115T3 (da) Kontinuerlig flertrinsfremgangsmåde til oprensning af antistoffer
IL263690A (en) Purification of multispecific antibodies
DK3268390T3 (da) Fremgangsmåder til oprensning af bispecifikke antistoffer
DK3043816T3 (da) Anti-b7-h1-antistoffer til behandling af tumorer
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK3680000T3 (da) Fremgangsmåder til oprensning af antistoffer
DK3116891T3 (da) Immunglobulinrensning ved hjælp af forrensningstrin
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK2983787T3 (da) Fremgangsmåde til behandling af posttraumatisk stresssygdom
DK3113858T3 (da) Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
DK3050896T3 (da) Fremgangsmåde til fremstilling af en polypeptid-heteromultimer
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
DK3076967T3 (da) Fremgangsmåder til behandling af residuelle symptomer på skizofreni
DK2970954T3 (da) Modifikation af polypeptider
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK3006568T3 (da) Fremgangsmåde til fremstilling af tagatose
DK2968208T3 (da) Behandling af kataplexi
DK2953904T3 (da) Fremgangsmåde til kontrolleret fremstilling af et biocid
DK3054976T3 (da) Anvendelse af semaphorin-4d-bindende molekyler til behandling af aterosklerose
DK3016991T3 (da) Sammensætninger til formning af væsker
DK2976359T4 (da) Fremgangsmåder til behandling af osteogenesis imperfecta
DK2962754T3 (da) Fremgangsmåde til fremstilling af co-shiftkatalysator
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK3010352T3 (da) Fremgangsmåde til fremstilling af fodertilsætning